ALEMBICLTDNSEAlembic Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 26 Sept · 17:32 IST

Alembic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alembic Limited has informed the exchanges that its trading window will remain closed starting 1st October 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter and half year ended 30th September 2025 (Q2 FY26). During this period, designated persons and their immediate relatives are prohibited from trading in the company's securities. The date of the board meeting to approve these results will be communicated separately.

Likely market impact

This is a routine regulatory compliance filing and does not directly impact shareholders. However, it signals that the Q2 FY26 earnings announcement is approaching, which is typically a key event that can influence short-term stock movement.